Skip to content

AGIOS PHARMACEUTICALS, INC.

AGIO

CIK 0001439222 · Pharmaceutical Preparations · Nasdaq

  • AGIOS PHARMACEUTICALS INC (until 2019-07-16)
← back to feed
Revenue (TTM)
$54.81M
+48.0% YoY Q1 Apr 2026
Net Income (TTM)
−$403.85M
−161.3% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$6.95
−161.2% YoY Q1 Apr 2026
Gross Margin
89.4%
Q1 Apr 2026
Operating Margin
-840.4%
Q1 Apr 2026
Net Margin
-736.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$427.53M
Q1 Apr 2026
Cash
$113.6M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
59.47M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings